Deal Announcement 10/23: Healthcare

PwC acted as exclusive financial advisor to the private shareholder of Digithurst Bildverarbeitungssysteme GmbH & Co. KG, a leading provider of radiology software solutions, on its combination with competitor medavis, a portfolio company of the family investor Bregal Unternehmerkapital

The Deal

The PwC M&A team is pleased to announce the successful sale of Digithurst Bildverarbeitungssysteme GmbH & Co. KG (“Digithurst”) to the shareholder of medavis GmbH (“medavis”), a portfolio company of Bregal Unternehmerkapital. Digithurst is a leading provider of Radiology Information Systems (RIS) and Picture Archiving and Communication Systems (PACS) solutions.

Digithurst and medavis join forces to form a leading provider of RIS and PACS solutions. The combination enables the group to bring new innovative software solutions to the radiology market while continuing to further develop existing product lines.

The share purchase agreement was signed in September 2023 and closed in October 2023.

The sale of Digithurst marks PwC’s second successfully completed vendor mandate in the radiology software space following the sale of Visus to CompuGroup Medical in 2021.


Digithurst is an owner-operated digital health and software company that develops and markets RIS, PACS, and portal solutions for radiological institutions, mainly imaging centers and hospitals.


Medavis with its headquarter in Karlsruhe, a portfolio company of the family investor Bregal Unternehmerkapital, is the leading RIS software provider in the DACH region, serving radiologists, referring physicians, hospitals and patients with solutions for location-independent networking in the radiology sector.


The global PricewaterhouseCoopers network is a worldwide association of independent auditing and consulting companies which together employ more than 364,000 people in 152 countries. Our global network comprises over 2,900 M&A professionals all over the world, realising approx. 400 successful transactions per year. We specialise in a wide range of independent M&A services including advice on acquisitions and disposals, mergers, public takeovers, privatisations as well as structured financing.

PwC M&A Germany acted as exclusive financial advisor to the private shareholder on this transaction. The transaction was led by Dr. Alexander von Friesen (Partner) and supported by Julian Fischer (Senior Associate) and Lucas Busch (Senior Associate).

PwC Legal provided legal advice on the transaction led by Gerhard Wacker (Partner) and Moritz Gröning (Partner) who were supported by Dr. Fabian Jenderek (Senior Manager), Valentin Ganzer (Senior Associate), Lars Spiller (Senior Manager), Gloria Müller (Senior Associate), Tomke Blendermann (Senior Associate), Dr. Tobias von Tucher (Partner), Lukas Lundbeck (Senior Manager), Dinor Kadrijaj (Senior Associate) and Janina Thieme (Manager).

Contact us

Dr. Alexander von Friesen

Dr. Alexander von Friesen

Partner, Corporate Finance | M&A Healthcare & Consumer, PwC Germany

Tel: +49 151 11714398

Follow us